A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic nondiabetic patients referred for myocardial perfusion imaging: The COMPASS study

Circulation: Cardiovascular Genetics

Volumn 6, Issue 2, 2013, Pages 154-162

  Thomas, Gregory S ^a,b   Voros, Szilard ^c   McPherson, John A ^d   Lansky, Alexandra J ^e   Winn, Mary E ^f   Bateman, Timothy M ^g   Elashoff, Michael R ^h   Lieu, Hsiao D ^h   Johnson, Andrea M ^h   Daniels, Susan E ^h   Ladapo, Joseph A ⁱ   Phelps, Charles E ^j   Douglas, Pamela S ^k   Rosenberg, Steven ^h  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^g UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^h CardioDx Inc   (United States)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF ROCHESTER   (United States)

^k DUKE UNIVERSITY   (United States)

more..

Author keywords

Atherosclerosis; Computed tomography angiography; Coronary angiography; Gene expression; Myocardial perfusion imaging

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGE FACTORS; ALGORITHMS; AREA UNDER CURVE; CONSTRICTION, PATHOLOGIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NEUTROPHILS; PREVALENCE; PROSPECTIVE STUDIES; ROC CURVE; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878043953     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.964015     Document Type: Article

References (38)

1. The Myocardial Perfusion Study Monthly Monitor. Exton, PA: Arlington Medical Resources; 2009.
2. Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O'Gara P, et al; ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56:1864-1894.
3. Chen J, Einstein AJ, Fazel R, Krumholz HM, Wang Y, Ross JS, et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol. 2010;56:702-711.
4. Einstein AJ, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304:2137-2144.
5. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med. 2009;361:849-857.
6. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362:886-895.
7. Douglas PS, Patel MR, Bailey SR, Dai D, Kaltenbach L, Brindis RG, et al. Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. J Am Coll Cardiol. 2011;58:801-809.
8. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.
9. Elashoff MR, Wingrove JA, Beineke P, Daniels SE, Tingley WG, Rosenberg S, et al. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics. 2011;4:26.
10. Rosenberg S, Elashoff MR, Beineke P, Daniels SE, Wingrove JA, Tingley WG, et al PREDICT (Personalized Risk Evaluation and Diagnosis in the Coronary Tree) Investigators. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med. 2010;153:425-434.
11. Rosenberg S, Elashoff MR, Lieu HD, Brown BO, Kraus WE, Schwartz RS, et al. Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. J Cardiovasc Transl Res. 2012;2012:7.
12. Lansky A, Elashoff MR, Ng V, McPherson J, Lazar D, Kraus WE, et al. A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial. Am Heart J. 2012;164:320-326.
13. Arnett DK. Gene expression algorithm for prevalent coronary artery disease: a first step in a long journey. Ann Intern Med. 2010;153:473-474.
14. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-1358.
15. Morise AP. Comparison of the Diamond-Forrester method and a new score to estimate the pretest probability of coronary disease before exercise testing. Am Heart J. 1999;138(pt 1):740-745.
16. Morise AP, Haddad WJ, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med. 1997;102:350-356.
17. Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, et al Society of Cardiovascular Computed Tomography. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009;3:122-136.
18. Elashoff MR, Nuttall R, Beineke P, Doctolero MH, Dickson M, Johnson AM, et al. Identification of factors contributing to variability in a bloodbased gene expression test. PLoS ONE. 2012;7:e40068.
19. Diamond GA. Affirmative actions: can the discriminant accuracy of a test be determined in the face of selection bias? Med Decis Making. 1991;11:48-56.
20. RDC T. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2007.
21. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172.
22. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795-802.
23. Mudrick DW, Cowper PA, Shah BR, Patel MR, Jensen NC, Peterson ED, et al. Downstream procedures and outcomes after stress testing for chest pain without known coronary artery disease in the United States. Am Heart J. 2012;163:454-461.
24. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235.
25. Mark DB, Nelson CL, Califf RM, Harrell FE Jr, Lee KL, Jones RH, et al. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation. 1994;89:2015-2025.
26. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58:849-860.
27. Lin FY, Shaw LJ, Dunning AM, Labounty TM, Choi JH, Weinsaft JW, et al. Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography. J Am Coll Cardiol. 2011;58:510-519.
28. Blankstein R, Di Carli MF. Integration of coronary anatomy and myocardial perfusion imaging. Nat Rev Cardiol. 2010;7:226-236.
29. Hamirani YS, Isma'eel H, Larijani V, Drury P, Lim W, Bevinal M, et al. The diagnostic accuracy of 64-detector cardiac computed tomography compared with stress nuclear imaging in patients undergoing invasive cardiac catheterization. J Comput Assist Tomogr. 2010;34:645-651.
30. Schuijf JD, Wijns W, Jukema JW, Atsma DE, de Roos A, Lamb HJ, et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol. 2006;48:2508-2514.
31. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318-1333.
32. Thomas GS, Miyamoto MI, Morello AP 3rd, Majmundar H, Thomas JJ, Sampson CH, et al. Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting: the Nuclear Utility in the Community (NUC) Study. J Am Coll Cardiol. 2004;43:213-223.
33. Lubbers DD, Kuijpers D, Bodewes R, Kappert P, Kerkhof M, van Ooijen PM, et al. Inter-observer variability of visual analysis of "stress"- only adenosine first-pass myocardial perfusion imaging in relation to clinical experience and reading criteria. Int J Cardiovasc Imaging. 2011;27:557-562.
34. Roger VL, Pellikka PA, Bell MR, Chow CW, Bailey KR, Seward JB. Sex and test verification bias: impact on the diagnostic value of exercise echocardiography. Circulation. 1997;95:405-410.
35. Douglas PS. Is noninvasive testing for coronary artery disease accurate? Circulation. 1997;95:299-302.
36. Froelicher VF, Lehmann KG, Thomas R, Goldman S, Morrison D, Edson R, et al. The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction: Veterans Affairs Cooperative Study in Health Services #016 (QUEXTA) Study Group: Quantitative Exercise Testing and Angiography. Ann Intern Med. 1998;128(pt 1):965-974.
37. Mowatt G, Vale L, Brazzelli M, Hernandez R, Murray A, Scott N, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess. 2004;8:iii-iv, 1.
38. Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, et al SPARC Investigators. Patient management after noninvasive cardiac imaging results from SPARC (Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease). J Am Coll Cardiol. 2012;59:462-474.